As of 14 Sept 2024, Sun Pharma Advanced Research Company net assets is $5.13B, an increase of 1542.16% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Sun Pharma Advanced Research Company overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Year | Net assets | Change |
---|---|---|
2023 | $5.13B | 1542.16% |
2022 | $312.26M | -118.56% |
2021 | $-1.68B | 802.72% |
2020 | $-186.38M | -97.25% |
2019 | $-6.78B | - |